Photo from wikipedia
a University of Cincinnati Cancer Institute, Dept. of Ob/Gyn, University of Cincinnati, United States b Office of Hematology Oncology Products, OND, CDER, FDA, United States c Division of Gynecologic Oncology,… Click to show full abstract
a University of Cincinnati Cancer Institute, Dept. of Ob/Gyn, University of Cincinnati, United States b Office of Hematology Oncology Products, OND, CDER, FDA, United States c Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, TN, United States d Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, United States e Division of Biometrics V, OB, OTS, CDER, FDA, United States f Ovarian Cancer Alliance of San Diego, United States g Department of Gynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States h U.S. Oncology, Phoenix, AZ, United States i Oncology Center of Excellence, OMPT, FDA, United States j Ovarian Cancer Survivor, White Plains, New York
Journal Title: Gynecologic oncology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!